The Enterovirus Vaccine Market encompasses the research, development, production, and distribution of vaccines aimed at preventing infections caused by enteroviruses. Enteroviruses are a group of RNA viruses that include Coxsackieviruses and Enterovirus A71 (EV71), the latter being notably responsible for severe outbreaks of Hand, Foot, and Mouth Disease (HFMD). These infections primarily affect children under the age of five, with the most vulnerable being around two years old. The market specifically targets diseases such as HFMD, which first emerged in New Zealand in 1957 and has since become a major public health concern across Asia-Pacific and other regions.
Market Size
In 2024, the global Enterovirus Vaccine market was valued at USD 326 million. The market is forecasted to grow at a compound annual growth rate (CAGR) of 5.80%, reaching an estimated value of USD 541.49 million by 2032.
This growth trajectory is driven by increasing demand for preventive healthcare, expanding vaccine immunization programs in Asia-Pacific, and ongoing research for broader-spectrum multivalent vaccines. Regionally, North America accounted for USD 93.60 million in 2024 and is projected to experience a CAGR of 4.97% through 2032, reflecting steady adoption despite a relatively lower prevalence compared to Asia-Pacific.
Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)
Drivers
-
Rising HFMD Incidence: The increasing number of HFMD cases, especially in densely populated regions like Southeast Asia, drives the demand for effective vaccines.
-
Government Immunization Programs: Supportive government policies, particularly in China, have bolstered EV71 vaccine adoption.
-
High Vaccine Efficacy: Licensed EV71 vaccines show up to 97.4% efficacy after one year, boosting trust and uptake.
Restraints
-
Limited Vaccine Scope: Most licensed vaccines target the C4 genogroup, leaving a gap for other enterovirus strains.
-
Regulatory Challenges: Stringent regulatory requirements, especially for multivalent and recombinant vaccines, slow the approval pipeline.
Opportunities
-
Multivalent Vaccine Development: Ongoing research into vaccines covering Coxsackie A16, A6, A10, and EV71 could result in broader immunization offerings.
-
Emerging Markets: Latin America and Africa offer untapped potential due to rising healthcare investment and growing awareness.
Challenges
-
Vaccine Hesitancy: In some regions, misinformation and lack of awareness can hinder vaccine adoption.
-
Manufacturing Limitations: High costs and complex production processes for recombinant and virus-like particle vaccines can act as bottlenecks.
Regional Analysis
-
Asia-Pacific: The dominant region, especially China, due to early outbreaks, government-backed immunization drives, and local manufacturers like Sinovac and Shenzhen Neptunus.
-
North America: Strong R&D and favorable healthcare infrastructure contribute to steady market growth.
-
Europe: Moderate growth supported by public awareness and ongoing research, with countries like Germany and the UK playing a key role.
-
Latin America: Growing healthcare expenditure in Brazil and Argentina is encouraging vaccine rollout.
-
Middle East & Africa: Currently in nascent stages but showing promise due to increasing attention to child healthcare.
Competitor Analysis
The Enterovirus Vaccine market features several key players:
-
Sinovac Biotech and Sinopharm: Leading the market with licensed EV71 vaccines.
-
Medigen Vaccine Biologics and Adimmune: Focusing on vaccine development using alternative strains.
-
Shenzhen Neptunus and Beijing Minhai Biotechnology: Prominent in the Asia-Pacific region.
-
Intravacc and Shanghai Zerun Biotechnology: Known for early-stage research and advanced formulations like virus-like particle vaccines.
These companies are leveraging collaborations, expanding product portfolios, and enhancing production capacities to gain competitive advantage.
Global Enterovirus Vaccine Market: Market Segmentation Analysis
This report provides a deep insight into the global Enterovirus Vaccine market, covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and assessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Enterovirus Vaccine Market. This report introduces in detail the market share, market performance, product situation, operation situation, etc., of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Enterovirus Vaccine market in any manner.
Market Segmentation (by Application)
-
Hospital
-
Research Institute
-
Others
Market Segmentation (by Type)
-
Coxasckievirus A
-
Coxasckievirus B
-
Human Enterovirus 71
-
Others
Key Company
-
Sinovac Biotech
-
Medigen Vaccine Biologics
-
Shenzhen Neptunus
-
Sinopharm
-
Adimmune
-
Intravacc
-
Shanghai Zerun Biotechnology
-
Beijing Minhai Biotechnology
Geographic Segmentation
-
North America (USA, Canada, Mexico)
-
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
-
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
-
South America (Brazil, Argentina, Columbia, Rest of South America)
-
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
FAQ
What is the current market size of the Enterovirus Vaccine market?
- As of 2024, the Enterovirus Vaccine market size is valued at USD 326 million.
Which are the key companies operating in the Enterovirus Vaccine market?
- Notable players include Sinovac Biotech, Sinopharm, Medigen Vaccine Biologics, Adimmune, and Shenzhen Neptunus, among others.
What are the key growth drivers in the Enterovirus Vaccine market?
- Key drivers include rising HFMD incidence, effective vaccine efficacy rates, and robust government immunization policies.
Which regions dominate the Enterovirus Vaccine market?
- Asia-Pacific, particularly China, dominates due to early outbreaks and government-backed programs.
What are the emerging trends in the Enterovirus Vaccine market?
- Trends include multivalent vaccine development, virus-like particle vaccine research, and expansion into emerging markets such as Africa and Latin America.
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Enterovirus Vaccine Market
- Overview of the regional outlook of the Enterovirus Vaccine Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
- In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
- Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
- Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enterovirus Vaccine Market and its likely evolution in the short to mid-term, and long term.
- Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
- Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
- Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 9 shares the main producing countries of Enterovirus Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
- Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
- Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
- Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
- Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Enterovirus Vaccine
1.2 Key Market Segments
1.2.1 Enterovirus Vaccine Segment by Type
1.2.2 Enterovirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Enterovirus Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Enterovirus Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Enterovirus Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Enterovirus Vaccine Market Competitive Landscape
3.1 Global Enterovirus Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Enterovirus Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Enterovirus Vaccine Sales Sites, Area Served, Product Type
3.6 Enterovirus Vaccine Market Competitive Situation and Trends
3.6.1 Enterovirus Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Enterovirus Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Enterovirus Vaccine Industry Chain Analysis
4.1 Enterovirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Enterovirus Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Enterovirus Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enterovirus Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Enterovirus Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Enterovirus Vaccine Price by Type (2019-2025)
7 Enterovirus Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enterovirus Vaccine Market Sales by Application (2019-2025)
7.3 Global Enterovirus Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Enterovirus Vaccine Sales Growth Rate by Application (2019-2025)
8 Enterovirus Vaccine Market Consumption by Region
8.1 Global Enterovirus Vaccine Sales by Region
8.1.1 Global Enterovirus Vaccine Sales by Region
8.1.2 Global Enterovirus Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Enterovirus Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Enterovirus Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Enterovirus Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Enterovirus Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Enterovirus Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Enterovirus Vaccine Market Production by Region
9.1 Global Production of Enterovirus Vaccine by Region (2019-2025)
9.2 Global Enterovirus Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Enterovirus Vaccine Production
9.4.1 North America Enterovirus Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Enterovirus Vaccine Production
9.5.1 Europe Enterovirus Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Enterovirus Vaccine Production (2019-2025)
9.6.1 Japan Enterovirus Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Enterovirus Vaccine Production (2019-2025)
9.7.1 China Enterovirus Vaccine Production Growth Rate (2019-2025)
9.7.2 China Enterovirus Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sinovac Biotech
10.1.1 Sinovac Biotech Enterovirus Vaccine Basic Information
10.1.2 Sinovac Biotech Enterovirus Vaccine Product Overview
10.1.3 Sinovac Biotech Enterovirus Vaccine Product Market Performance
10.1.4 Sinovac Biotech Business Overview
10.1.5 Sinovac Biotech Enterovirus Vaccine SWOT Analysis
10.1.6 Sinovac Biotech Recent Developments
10.2 Medigen Vaccine Biologics
10.2.1 Medigen Vaccine Biologics Enterovirus Vaccine Basic Information
10.2.2 Medigen Vaccine Biologics Enterovirus Vaccine Product Overview
10.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Product Market Performance
10.2.4 Medigen Vaccine Biologics Business Overview
10.2.5 Medigen Vaccine Biologics Enterovirus Vaccine SWOT Analysis
10.2.6 Medigen Vaccine Biologics Recent Developments
10.3 Shenzhen Neptunus
10.3.1 Shenzhen Neptunus Enterovirus Vaccine Basic Information
10.3.2 Shenzhen Neptunus Enterovirus Vaccine Product Overview
10.3.3 Shenzhen Neptunus Enterovirus Vaccine Product Market Performance
10.3.4 Shenzhen Neptunus Enterovirus Vaccine SWOT Analysis
10.3.5 Shenzhen Neptunus Business Overview
10.3.6 Shenzhen Neptunus Recent Developments
10.4 Sinopharm
10.4.1 Sinopharm Enterovirus Vaccine Basic Information
10.4.2 Sinopharm Enterovirus Vaccine Product Overview
10.4.3 Sinopharm Enterovirus Vaccine Product Market Performance
10.4.4 Sinopharm Business Overview
10.4.5 Sinopharm Recent Developments
10.5 Adimmune
10.5.1 Adimmune Enterovirus Vaccine Basic Information
10.5.2 Adimmune Enterovirus Vaccine Product Overview
10.5.3 Adimmune Enterovirus Vaccine Product Market Performance
10.5.4 Adimmune Business Overview
10.5.5 Adimmune Recent Developments
10.6 Intravacc
10.6.1 Intravacc Enterovirus Vaccine Basic Information
10.6.2 Intravacc Enterovirus Vaccine Product Overview
10.6.3 Intravacc Enterovirus Vaccine Product Market Performance
10.6.4 Intravacc Business Overview
10.6.5 Intravacc Recent Developments
10.7 Shanghai Zerun Biotechnology
10.7.1 Shanghai Zerun Biotechnology Enterovirus Vaccine Basic Information
10.7.2 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Overview
10.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Market Performance
10.7.4 Shanghai Zerun Biotechnology Business Overview
10.7.5 Shanghai Zerun Biotechnology Recent Developments
10.8 Beijing Minhai Biotechnology
10.8.1 Beijing Minhai Biotechnology Enterovirus Vaccine Basic Information
10.8.2 Beijing Minhai Biotechnology Enterovirus Vaccine Product Overview
10.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Product Market Performance
10.8.4 Beijing Minhai Biotechnology Business Overview
10.8.5 Beijing Minhai Biotechnology Recent Developments
11 Enterovirus Vaccine Market Forecast by Region
11.1 Global Enterovirus Vaccine Market Size Forecast
11.2 Global Enterovirus Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Enterovirus Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Enterovirus Vaccine Market Size Forecast by Region
11.2.4 South America Enterovirus Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Enterovirus Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Enterovirus Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Enterovirus Vaccine by Type (2025-2032)
12.1.2 Global Enterovirus Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Enterovirus Vaccine by Type (2025-2032)
12.2 Global Enterovirus Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Enterovirus Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Enterovirus Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Enterovirus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Enterovirus Vaccine Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Enterovirus Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Enterovirus Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Enterovirus Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2022)
Table 10. Global Market Enterovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Enterovirus Vaccine Sales Sites and Area Served
Table 12. Manufacturers Enterovirus Vaccine Product Type
Table 13. Global Enterovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Enterovirus Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enterovirus Vaccine Market Challenges
Table 22. Global Enterovirus Vaccine Sales by Type (K Units)
Table 23. Global Enterovirus Vaccine Market Size by Type (M USD)
Table 24. Global Enterovirus Vaccine Sales (K Units) by Type (2019-2025)
Table 25. Global Enterovirus Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Enterovirus Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Enterovirus Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Enterovirus Vaccine Price (USD/Unit) by Type (2019-2025)
Table 29. Global Enterovirus Vaccine Sales (K Units) by Application
Table 30. Global Enterovirus Vaccine Market Size by Application
Table 31. Global Enterovirus Vaccine Sales by Application (2019-2025) & (K Units)
Table 32. Global Enterovirus Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Enterovirus Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Enterovirus Vaccine Market Share by Application (2019-2025)
Table 35. Global Enterovirus Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Enterovirus Vaccine Sales by Region (2019-2025) & (K Units)
Table 37. Global Enterovirus Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Enterovirus Vaccine Sales by Country (2019-2025) & (K Units)
Table 39. Europe Enterovirus Vaccine Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Enterovirus Vaccine Sales by Region (2019-2025) & (K Units)
Table 41. South America Enterovirus Vaccine Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Enterovirus Vaccine Sales by Region (2019-2025) & (K Units)
Table 43. Global Enterovirus Vaccine Production (K Units) by Region (2019-2025)
Table 44. Global Enterovirus Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Enterovirus Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Enterovirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Sinovac Biotech Enterovirus Vaccine Basic Information
Table 52. Sinovac Biotech Enterovirus Vaccine Product Overview
Table 53. Sinovac Biotech Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Sinovac Biotech Business Overview
Table 55. Sinovac Biotech Enterovirus Vaccine SWOT Analysis
Table 56. Sinovac Biotech Recent Developments
Table 57. Medigen Vaccine Biologics Enterovirus Vaccine Basic Information
Table 58. Medigen Vaccine Biologics Enterovirus Vaccine Product Overview
Table 59. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Medigen Vaccine Biologics Business Overview
Table 61. Medigen Vaccine Biologics Enterovirus Vaccine SWOT Analysis
Table 62. Medigen Vaccine Biologics Recent Developments
Table 63. Shenzhen Neptunus Enterovirus Vaccine Basic Information
Table 64. Shenzhen Neptunus Enterovirus Vaccine Product Overview
Table 65. Shenzhen Neptunus Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Shenzhen Neptunus Enterovirus Vaccine SWOT Analysis
Table 67. Shenzhen Neptunus Business Overview
Table 68. Shenzhen Neptunus Recent Developments
Table 69. Sinopharm Enterovirus Vaccine Basic Information
Table 70. Sinopharm Enterovirus Vaccine Product Overview
Table 71. Sinopharm Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Sinopharm Business Overview
Table 73. Sinopharm Recent Developments
Table 74. Adimmune Enterovirus Vaccine Basic Information
Table 75. Adimmune Enterovirus Vaccine Product Overview
Table 76. Adimmune Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Adimmune Business Overview
Table 78. Adimmune Recent Developments
Table 79. Intravacc Enterovirus Vaccine Basic Information
Table 80. Intravacc Enterovirus Vaccine Product Overview
Table 81. Intravacc Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Intravacc Business Overview
Table 83. Intravacc Recent Developments
Table 84. Shanghai Zerun Biotechnology Enterovirus Vaccine Basic Information
Table 85. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Overview
Table 86. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Shanghai Zerun Biotechnology Business Overview
Table 88. Shanghai Zerun Biotechnology Recent Developments
Table 89. Beijing Minhai Biotechnology Enterovirus Vaccine Basic Information
Table 90. Beijing Minhai Biotechnology Enterovirus Vaccine Product Overview
Table 91. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Beijing Minhai Biotechnology Business Overview
Table 93. Beijing Minhai Biotechnology Recent Developments
Table 94. Global Enterovirus Vaccine Sales Forecast by Region (2025-2032) & (K Units)
Table 95. Global Enterovirus Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Enterovirus Vaccine Sales Forecast by Country (2025-2032) & (K Units)
Table 97. North America Enterovirus Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Enterovirus Vaccine Sales Forecast by Country (2025-2032) & (K Units)
Table 99. Europe Enterovirus Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Enterovirus Vaccine Sales Forecast by Region (2025-2032) & (K Units)
Table 101. Asia Pacific Enterovirus Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Enterovirus Vaccine Sales Forecast by Country (2025-2032) & (K Units)
Table 103. South America Enterovirus Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Enterovirus Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Enterovirus Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Enterovirus Vaccine Sales Forecast by Type (2025-2032) & (K Units)
Table 107. Global Enterovirus Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Enterovirus Vaccine Price Forecast by Type (2025-2032) & (USD/Unit)
Table 109. Global Enterovirus Vaccine Sales (K Units) Forecast by Application (2025-2032)
Table 110. Global Enterovirus Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Enterovirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enterovirus Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Enterovirus Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Enterovirus Vaccine Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enterovirus Vaccine Market Size by Country (M USD)
Figure 11. Enterovirus Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Enterovirus Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Enterovirus Vaccine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Enterovirus Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Enterovirus Vaccine Market Share by Type
Figure 18. Sales Market Share of Enterovirus Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Enterovirus Vaccine by Type in 2023
Figure 20. Market Size Share of Enterovirus Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Enterovirus Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Enterovirus Vaccine Market Share by Application
Figure 24. Global Enterovirus Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Enterovirus Vaccine Sales Market Share by Application in 2023
Figure 26. Global Enterovirus Vaccine Market Share by Application (2019-2025)
Figure 27. Global Enterovirus Vaccine Market Share by Application in 2023
Figure 28. Global Enterovirus Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Enterovirus Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Enterovirus Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Enterovirus Vaccine Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Enterovirus Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Enterovirus Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Enterovirus Vaccine Sales Market Share by Region in 2023
Figure 44. China Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Enterovirus Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Enterovirus Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Enterovirus Vaccine Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Enterovirus Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Enterovirus Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Enterovirus Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Enterovirus Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 65. China Enterovirus Vaccine Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Enterovirus Vaccine Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Enterovirus Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Enterovirus Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Enterovirus Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Enterovirus Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Enterovirus Vaccine Market Share Forecast by Application (2025-2032)
